Edition:
United Kingdom

Aimmune Therapeutics Inc (AIMT.OQ)

AIMT.OQ on NASDAQ Stock Exchange Global Select Market

18.09USD
18 Jul 2019
Change (% chg)

-- (--)
Prev Close
$18.09
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
182,701
52-wk High
$36.12
52-wk Low
$16.97

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.00 -0.875
FY 2018 Dec '18 0.00 -0.953
Sep '18 0.00 -0.887
Jun '18 0.00 -0.908
Mar '18 0.00 -0.924
FY 2017 Dec '17 0.00 -0.281
Sep '17 0.00 -0.630
Jun '17 0.00 -0.647
Mar '17 0.00 -0.517
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 9 0.00 0.00 0.00 13.33
Quarter Ending Dec-19 9 0.00 0.00 0.00 19.81
Year Ending Dec-19 9 0.00 0.00 0.00 40.56
Year Ending Dec-20 10 64.51 127.95 35.00 263.10
Earnings (per share)
Quarter Ending Sep-19 10 -0.98 -0.87 -1.12 -0.63
Quarter Ending Dec-19 10 -1.03 -0.89 -1.19 -0.53
Year Ending Dec-19 10 -3.84 -3.49 -4.24 -2.85
Year Ending Dec-20 10 -3.15 -2.01 -4.48 0.75
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 96.93 34.10
P/E High - Last 5 Yrs. -- 167.87 54.36
P/E Low - Last 5 Yrs. -- 53.01 28.26
Beta -0.11 1.28 0.99
Price to Sales (TTM) -- 41.81 7.99
Price to Book (MRQ) 4.41 12.10 4.39
Price to Tangible Book (MRQ) 4.41 16.99 5.11
Price to Cash Flow (TTM) -- 63.65 24.00
% Owned Institutions 86.27 3.26 1.78

Dividends

  Company industry sector
Dividend Yield -- 0.11 1.65
Dividend Yield - 5 Year Avg -- 0.05 1.37
Dividend 5 Year Growth Rate -- 0.87 6.79
Payout Ratio(TTM) -- 2.13 47.36

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 66.82 14.82
Sales (TTM) vs TTM 1 Yr. Ago -- 48.75 8.25
Sales - 5 Yr. Growth Rate -- 33.30 9.51
EPS (MRQ) vs Qtr. 1 Yr. Ago 5.30 -6.57 18.20
EPS (TTM) vs TTM 1 Yr. Ago -45.99 -- --
EPS - 5 Yr. Growth Rate -- 22.53 7.10
Capital Spending - 5 Yr. Growth Rate 167.33 26.33 7.89

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.78 2.53
Current Ratio (MRQ) 7.65 3.88 3.53
LT Debt to Equity (MRQ) 14.54 7.94 12.82
Total Debt to Equity (MRQ) 14.54 21.02 17.94
Interest Coverage (TTM) -- 32.39 14.83

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 22.77 50.22
Gross Margin - 5 Yr. Avg. -- 58.95 51.36
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -11.93 16.44
Operating Margin (TTM) -- -122.82 -6.57
Operating Margin - 5 Yr. Avg. -- -28.22 11.92
Pre-Tax Margin (TTM) -- -124.67 -6.93
Pre-Tax Margin - 5 Yr. Avg. -- -33.59 15.92
Net Profit Margin (TTM) -- -130.36 -10.72
Net Profit Margin - 5 Yr. Avg. -- -38.53 11.28
Effective Tax Rate (TTM) -- 17.17 20.52
Effective Tax Rate - 5 Yr. Avg. -- 18.82 24.48

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 9,719,719 871,354,112
Net Income/Employee (TTM) -1,002,409 2,153,840 101,932,718
Receivable Turnover (TTM) -- 12.14 5.89
Inventory Turnover (TTM) -- 2.41 3.65
Asset Turnover (TTM) 0.00 0.33 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -61.05 6.39 10.21
Return on Assets - 5 Yr. Avg. -49.41 6.14 11.16
Return on Investment (TTM) -67.61 7.71 12.64
Return on Investment - 5 Yr. Avg. -53.22 8.00 14.13
Return on Equity (TTM) -73.63 8.16 17.18
Return on Equity - 5 Yr. Avg. -55.33 8.95 15.51
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -77.20 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aimmune Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -5.38 -7.22 99 1
13 Week -6.91 -9.53 99 12
26 Week -19.09 -29.07 99 18
52 Week -35.84 -39.60 99 5
YTD -20.61 -33.31 87 5
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 86.27%
# of Holders: 184
Total Shares Held: 53,911,438
3 Mo. Net Change: 271,029
# New Positions: 3
# Closed Positions: 1
# Increased Positions: 7
# Reduced Positions: 11
# Net Buyers: -4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.